<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">ESC Heart Fail</journal-id><journal-id journal-id-type="iso-abbrev">ESC Heart Fail</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2055-5822</journal-id><journal-id journal-id-type="publisher-id">EHF2</journal-id><journal-title-group><journal-title>ESC Heart Failure</journal-title></journal-title-group><issn pub-type="epub">2055-5822</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6410537</article-id><article-id pub-id-type="pmid">28834655</article-id><article-id pub-id-type="doi">10.1002/ehf2.12036</article-id><article-id pub-id-type="publisher-id">EHF212036</article-id><article-id pub-id-type="other">ESCHF-2015-03-0026</article-id><article-categories><subj-group subj-group-type="overline"><subject>Editorial</subject></subj-group><subj-group subj-group-type="heading"><subject>Editorials</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Heart failure in Southeast Asia: facts and numbers </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="right-running-head">HF in Southeast Asia</alt-title><alt-title alt-title-type="left-running-head">C.S.P. Lam</alt-title></title-group><contrib-group><contrib id="ehf212036-cr-0001" contrib-type="author" corresp="yes"><name><surname>Lam</surname><given-names>Carolyn S.P.</given-names></name><xref ref-type="aff" rid="ehf212036-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="ehf212036-aff-0001">
<label><sup>1</sup></label>
<institution>National Heart Centre Singapore</institution>
<named-content content-type="street">5 Hospital Drive</named-content>
<country country="SG">Singapore</country>
<named-content content-type="post-code">169609</named-content>
<named-content content-type="city">Duke‐NUS</named-content>
<named-content content-type="street">8 College Road</named-content>
<country country="SG">Singapore</country>
<named-content content-type="post-code">169857</named-content>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>Correspondence to: Carolyn S.P. Lam, National Heart Centre Singapore, 5 Hospital Drive, Singapore 169609. Tel: +65‐67048965. Email: <email>carolyn_lam@nuhs.edu.sg</email></corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2015</year></pub-date><volume>2</volume><issue>2</issue><issue-id pub-id-type="doi">10.1002/ehf2.v2.2</issue-id><fpage>46</fpage><lpage>49</lpage><history><date date-type="received"><day>23</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>23</day><month>3</month><year>2015</year></date></history><permissions><copyright-statement content-type="article-copyright">© 2015 The Authors. ESC Heart Failure published by John Wiley &amp; Sons Ltd on behalf of the European Society of Cardiology.</copyright-statement><license license-type="creativeCommonsBy-nc-nd"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:EHF2-2-46.pdf"/><abstract><title><text><SENT sid="1" pm="."><plain>Abstract </plain></SENT>
</text></title><p><SecTag type="ABS"><text><SENT sid="2" pm="."><plain>Southeast Asia is home to a growing population of &gt;600 million people, the majority younger than 65 years, but among whom, rapid epidemiological transition has led to high rates of premature death from non‐communicable diseases (chiefly cardiovascular disease) (up to 28% in the Philippines vs. 12% in UK). </plain></SENT>
<SENT sid="3" pm="."><plain>There is a strikingly high prevalence of stage A heart failure (HF) risk factors in Southeast Asia, particularly hypertension (&gt;24% in Cambodia and Laos vs. 13–15% in UK and USA), tobacco smoking (&gt;36% in Indonesia), physical inactivity (&gt;50% in Malaysia) and raised blood glucose (10–11% in Brunei, Malaysia, Singapore and Thailand) in spite of a low prevalence of overweight/obesity (21–26% in Southeast Asia vs. 67–70% in UK and USA). </plain></SENT>
<SENT sid="4" pm="."><plain>Accordingly, the prevalence of symptomatic HF appears to be higher in Southeast Asian countries compared with the rest of the world. </plain></SENT>
<SENT sid="5" pm="."><plain>Epidemiologic trends in Singapore showed a sharp 38% increase in age‐adjusted HF hospitalizations (from 85.4 per 10 000 in 1991 to 110.3 per 10 000 in 1998) with notable ethnic differences (hospitalization rates ~35% higher in Malays and Indians vs. Chinese; mortality 3.5 times higher in Malays vs. Indians and Chinese). </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, Southeast Asian patients present with acute HF at a younger age (54 years) compared with USA patients (75 years) but have more severe clinical features, higher rates of mechanical ventilation, longer lengths of stay (6 vs. 4.2 days) and higher in‐hospital mortality (4.8 vs. 3.0%). </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, there is under‐usage of guideline‐recommended HF medical therapies (prescribed in 31–63% of patients upon discharge) and device therapies in Southeast Asia. </plain></SENT>
<SENT sid="8" pm="."><plain>Large gaps in knowledge that need to be addressed in Southeast Asia include the prevalence of HF with preserved ejection fraction, clinical outcomes, barriers to recommended therapies and their cost‐effectiveness, as well as possible ethnicity‐specific pathophysiologic mechanisms. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group kwd-group-type="author-generated"><kwd id="ehf212036-kwd-0001">Heart failure</kwd><kwd id="ehf212036-kwd-0002">Southeast Asia</kwd><kwd id="ehf212036-kwd-0003">Epidemiology</kwd><kwd id="ehf212036-kwd-0004">Ethnicity</kwd></kwd-group></SecTag><counts><page-count count="4"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>ehf212036</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2015</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.1 mode:remove_FC converted:11.03.2019</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="ehf212036-cit-0000">
<string-name>
<surname>Lam</surname>, <given-names>C. S.</given-names>
</string-name> (<year>2015</year>), <article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Heart failure in Southeast Asia: facts and numbers </plain></SENT>
</text></SecTag></article-title>. <source xml:lang="en">ESC Heart Failure</source>, <volume>2</volume>, <fpage>46</fpage>–<lpage>49</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ehf2.12036</pub-id>.<pub-id pub-id-type="pmid">28834655</pub-id></mixed-citation>
</p></notes></front><body><p><text><SENT sid="1" pm="."><plain>Southeast Asia refers to the geographic sub‐region of Asia south of China, east of India, west of New Guinea and north of Australia and includes the states of the Association of Southeast Asian Nations (Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam) (Table 1). </plain></SENT>
<SENT sid="2" pm="."><plain>The region is notable for its unique history and sociocultural heterogeneity and is home to a rapidly growing population of &gt;600 million people, the majority of whom are younger than 65 years. </plain></SENT>
<SENT sid="3" pm="."><plain>Recent globalisation and development have led to a rapid epidemiological transition in the region, as evidenced by a reduction in deaths from communicable diseases, an increase in average life expectancy, and an epidemic rise in non‐communicable diseases, chief among which is cardiovascular disease. </plain></SENT>
<SENT sid="4" pm="."><plain>In fact, according to the World Health Organization 2014 global status report, the probability of premature death from non‐communicable diseases far exceeds that of the UK (12.0%) in many countries in Southeast Asia, with more than double the risk in the Philippines (27.9%), Myanmar (24.3%) and Laos (24.2%). </plain></SENT>
<SENT sid="5" pm="."><plain>The risk of premature death from non‐communicable diseases is also high in Indonesia (23.1%), Malaysia (19.6%), Cambodia (17.7%), Vietnam (17.4%), Brunei (16.8%) and Thailand (16.2%); with Singapore (10.2%) being the only exception with comparable risk with the UK. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="ehf212036-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p><text><SENT sid="6" pm="."><plain>Prevalence of Stage A HF cardiovascular risk factors in Southeast Asian nations compared with the United Kingdom and United States of America (from the World Health Organization Global Status Report 2014) </plain></SENT>
</text></p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="center" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><col align="char" char="(" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th rowspan="2" align="left" valign="bottom" colspan="1"><text><SENT sid="7" pm="."><plain>Country </plain></SENT>
</text></th><th rowspan="2" align="center" valign="bottom" colspan="1"><text><SENT sid="8" pm="."><plain>World Bank Income Group Classification </plain></SENT>
</text></th><th colspan="5" align="center" valign="bottom" rowspan="1"><text><SENT sid="9" pm="."><plain>Prevalence in population aged 18+ years (crude adjusted estimates with 95% Confidence Interval) </plain></SENT>
</text></th></tr><tr style="border-bottom:solid 1px #000000"><th align="center" valign="bottom" rowspan="1" colspan="1"><text><SENT sid="10" pm="."><plain>insufficient physical activity </plain></SENT>
</text></th><th align="center" valign="bottom" rowspan="1" colspan="1"><text><SENT sid="11" pm="."><plain>Current tobacco smokinga </plain></SENT>
</text></th><th align="center" valign="bottom" rowspan="1" colspan="1"><text><SENT sid="12" pm="."><plain>Overweightb </plain></SENT>
</text></th><th align="center" valign="bottom" rowspan="1" colspan="1"><text><SENT sid="13" pm="."><plain>Raised blood glucosec </plain></SENT>
</text></th><th align="center" valign="bottom" rowspan="1" colspan="1"><text><SENT sid="14" pm="."><plain>Raised blood pressured </plain></SENT>
</text></th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="15" pm="."><plain>Brunei </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="16" pm="."><plain>High </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="17" pm="."><plain>— </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="18" pm="."><plain>15.8 (6.7–26.6) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="19" pm="."><plain>47.8 (40.7–54.3) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="20" pm="."><plain>11.2 (5.1–17.1) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="21" pm="."><plain>19.3 (12.4–26.3) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="22" pm="."><plain>Cambodia </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="23" pm="."><plain>Low </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="24" pm="."><plain>9.7 (8.7–10.8) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="25" pm="."><plain>21.3 (16.0–27.5) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="26" pm="."><plain>16.4 (12.7–20.2) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="27" pm="."><plain>6.8 (3.6–10.3) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="28" pm="."><plain>24.4 (17.8–30.9) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="29" pm="."><plain>Indonesia </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="30" pm="."><plain>Lower middle </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="31" pm="."><plain>22.8 (18.0–28.1) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="32" pm="."><plain>36.5 (29.9–45.3) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="33" pm="."><plain>24.4 (19.9–28.9) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="34" pm="."><plain>8.0 (4.0–11.8) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="35" pm="."><plain>23.3 (17.7–29.1) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="36" pm="."><plain>Laos </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="37" pm="."><plain>Lower middle </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="38" pm="."><plain>9.0 (7.4–10.8) </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="39" pm="."><plain>— </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="40" pm="."><plain>16.6 (13.1–20.6) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="41" pm="."><plain>6.4 (3.4–9.4) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="42" pm="."><plain>24.1 (18.3–30.4) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="43" pm="."><plain>Malaysia </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="44" pm="."><plain>Upper middle </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="45" pm="."><plain>51.6 (46.3–56.8) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="46" pm="."><plain>23.6 (17.2–30.7) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="47" pm="."><plain>37.3 (31.9–42.6) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="48" pm="."><plain>9.9 (5.5–14.2) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="49" pm="."><plain>22.1 (16.4–27.8) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="50" pm="."><plain>Myanmar </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="51" pm="."><plain>Low </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="52" pm="."><plain>9.0 (7.4–10.9) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="53" pm="."><plain>22.6 (15.6–29.7) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="54" pm="."><plain>17.4 (13.4–21.2) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="55" pm="."><plain>6.3 (2.8–9.5) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="56" pm="."><plain>23.7 (17.7–30.4) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="57" pm="."><plain>Philippines </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="58" pm="."><plain>Lower middle </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="59" pm="."><plain>14.4 (3.3–42.2) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="60" pm="."><plain>27.0 (21.5–32.3) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="61" pm="."><plain>22.3 (18.1–26.6) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="62" pm="."><plain>6.0 (2.7–9.2) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="63" pm="."><plain>22.1 (16.2–28.2) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="64" pm="."><plain>Singapore </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="65" pm="."><plain>High </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="66" pm="."><plain>33.7 (31.3–36.1) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="67" pm="."><plain>15.6 (12.6‐19.6) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="68" pm="."><plain>34.6 (30.1–38.9) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="69" pm="."><plain>9.8 (6.1–13.9) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="70" pm="."><plain>14.1 (10.0–17.9) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>Thailand </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="72" pm="."><plain>Upper middle </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="73" pm="."><plain>14.6 (13.4–16) </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>— </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>31.6 (26.7–36.7) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>10.9 (6.3–15.5) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>21.3 (15.8–26.9) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>Vietnam </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>Lower middle </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>23.6 (16.2–32.5) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>24.3 (19.8–29.5) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>20.4 (16.2‐24.6) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>6.0 (3.1–8.9) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>22.2 (16.3–28.3) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>United Kingdom </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>High </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>40.0 (38.6–41.4) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>19.9 (16.2–23.5) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>66.7 (63.4–70.3) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>10.1 (6.9–13.7) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>15.2 (11.9–18.6) </plain></SENT>
</text></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>United States of America </plain></SENT>
</text></td><td align="center" valign="top" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>High </plain></SENT>
</text></td><td align="char" char="." valign="top" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>35.0 (32.5–37.6) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>18.0 (14.9–21.1) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>69.6 (66.0–73.5) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>10.5 (6.6–13.9) </plain></SENT>
</text></td><td align="char" char="(" valign="top" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>13.4 (10–17.1) </plain></SENT>
</text></td></tr></tbody></table><table-wrap-foot><fn id="ehf212036-note-0001"><label>a</label><p><text><SENT sid="99" pm="."><plain>In the population aged 15+ years. </plain></SENT>
</text></p></fn><fn id="ehf212036-note-0002"><label>b</label><p><text><SENT sid="100" pm="."><plain>Body mass index ≥25 kg/m2. </plain></SENT>
</text></p></fn><fn id="ehf212036-note-0003"><label>c</label><p><text><SENT sid="101" pm="."><plain>Fasting glucose ≥7.0 mmol/L or on medications for raised blood glucose or with history of diabetes. </plain></SENT>
</text></p></fn><fn id="ehf212036-note-0004"><label>d</label><p><text><SENT sid="102" pm="."><plain>Systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag><sec id="ehf212036-sec-0002"><title><text><SENT sid="103" pm="."><plain>Risk factors for heart failure in Southeast Asia </plain></SENT>
</text></title><p><text><SENT sid="104" pm="."><plain>The cardiovascular risk factors in Table 1 represent the population with Stage A HF; according to current international HF guidelines.1 In this context, striking features of Southeast Asian patients at risk of progression to symptomatic HF are observed. </plain></SENT>
<SENT sid="105" pm="."><plain>Firstly, the prevalence of hypertension in Southeast Asians is high (&gt;24% in Cambodia and Laos) compared with the UK (15.2%) or USA (13.4%). </plain></SENT>
<SENT sid="106" pm="."><plain>Secondly, in spite of a much lower prevalence of overweight/obesity (21.6–26.2% in Southeast Asia vs. 66.7% in UK and 69.6% in USA), raised blood glucose/diabetes is a notable risk factor among Southeast Asians, reaching similarly high prevalence in Brunei, Malaysia, Singapore and Thailand compared with the UK and USA. </plain></SENT>
<SENT sid="107" pm="."><plain>Finally, the high prevalence of smoking is of concern, with smoking rates much higher in Southeast Asian countries (up to 36.5% in Indonesia) than UK or USA, except in Brunei and Singapore. </plain></SENT>
<SENT sid="108" pm="."><plain>This adverse lifestyle habit, coupled with physical inactivity particularly in Malaysia (51.6%), may contribute to the high premature mortality from cardiovascular diseases in these Southeast Asian countries. </plain></SENT>
</text></p><p><text><SENT sid="109" pm="."><plain>These data have important implications for (1) a high population attributable risk of hypertension for the development of HF in Southeast Asia; (2) a strong cardiometabolic basis for HF in a unique ‘lean diabetic’ Southeast Asian phenotype, distinct from HF in Western patients where diabetes is closely linked to obesity; (3) public health preventive strategies that are urgently needed to reduce smoking and promote physical activity in Southeast Asia. </plain></SENT>
</text></p></sec><sec id="ehf212036-sec-0003"><title><text><SENT sid="110" pm="."><plain>Epidemiology of clinical heart failure in Southeast Asia </plain></SENT>
</text></title><p><text><SENT sid="111" pm="."><plain>In sharp contrast to the wealth of epidemiologic data on HF in Western populations, reliable population‐based data on the incidence, prevalence and secular trends of clinical (Stage C) HF are scarce in Southeast Asia. </plain></SENT>
<SENT sid="112" pm="."><plain>Limited single‐centre data in Malaysia and Singapore suggest that the prevalence of HF in Southeast Asian countries is higher compared with countries in the rest of the world (4.5–6.7% vs. 0.5–2% respectively) (Figure 1).2 In an epidemiologic survey of HF hospitalizations among the elderly (≥65 years old) in Singapore from 1991–1998 (n=15 774; 77% Chinese, 14% Malay and 10% Indians),3 a 38% increase in age‐adjusted HF hospitalization rates was clearly demonstrated (from 85.4 per 10 000 in 1991 to 110.3 per 10 000 in 1998), whereas mortality decreased by 20% (from 7.3 per 10 000 in 1991 to 6.1 per 10 000 in 1998). </plain></SENT>
<SENT sid="113" pm="."><plain>Interestingly, significant ethnic differences were observed, wherein HF hospitalization rates were ~35% higher in Malays and Indians compared with Chinese; and mortality was 3.5 times higher in Malays compared with both Indians and Chinese, with mortality rates climbing over 1991–1998 only among the Malays (but declining in Indians and Chinese). </plain></SENT>
<SENT sid="114" pm="."><plain>More contemporary (2002–2004) data from two centres in Singapore (n=668; 72% Chinese, 17% Malay and 11% Indian)4 confirmed higher HF readmission rates in Indians and Malays, as well as higher mortality rates in Malays. </plain></SENT>
<SENT sid="115" pm="."><plain>Whereas greater prevalence of diabetes and atherosclerotic vascular disease explained the higher event rates among Indians, the reasons for poorer prognosis among Malays remained unclear. </plain></SENT>
</text></p><fig fig-type="Figure" xml:lang="en" id="ehf212036-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><text><SENT sid="116" pm="."><plain>Proportion of the population living with heart failure in individual countries across the globe. </plain></SENT>
<SENT sid="117" pm="."><plain>H: Estimates based on a single centre. </plain></SENT>
<SENT sid="118" pm="."><plain>Reproduced from Ponikowski et al.2 under the terms of its CC‐BY‐NC‐ND license. </plain></SENT>
</text></p></caption><graphic id="nlm-graphic-1" xlink:href="EHF2-2-46-g001"/></fig></sec><sec id="ehf212036-sec-0004"><title><text><SENT sid="119" pm="."><plain>Unique characteristics of Southeast Asian patients with symptomatic heart failure </plain></SENT>
</text></title><p><text><SENT sid="120" pm="."><plain>To date, the best available published data allowing comparisons of Asian to Western patients hospitalized with acute HF are from the Acute Decompensated Heart Failure Registry (ADHERE) International‐Asia Pacific study that included the Southeast Asian countries of Indonesia, Philippines, Singapore and Thailand.5 In the overall cohort, Asian Pacific patients were younger (median age 67 years vs. 75 years), but yet had more severe clinical features and higher rates of mechanical ventilation, compared with patients in the parallel US‐based ADHERE registry.6 Specifically among Southeast Asian patients in the ADHERE‐Asia Pacific study, the mean age at presentation was even younger (54 years).7 Despite the younger age of patients, length of stay was longer (6 vs. 4.2 days), and in‐hospital mortality higher (4.8 vs. 3.0%), in ADHERE Asia‐Pacific compared with ADHERE US.6 Of note, ADHERE Asia‐Pacific (2006–2008) was not performed contemporaneously with ADHERE US (2005–2006), did not include long term follow‐up and was limited by missing data particularly with respect to echocardiographic and electrocardiographic data. </plain></SENT>
<SENT sid="121" pm="."><plain>Their limitations are being addressed in the ongoing simultaneous parallel multi‐centre studies in Singapore (Singapore Heart Failure Outcomes and Phenotypes Study) and New Zealand (Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction [PEOPLE] Study).8 </plain></SENT>
</text></p></sec><sec id="ehf212036-sec-0005"><title><text><SENT sid="122" pm="."><plain>Medical therapy of heart failure in Southeast Asia </plain></SENT>
</text></title><p><text><SENT sid="123" pm="."><plain>Under‐usage of disease‐modifying HF therapies was reported in the ADHERE Asia‐Pacific cohort, with angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers prescribed upon discharge in 63%, beta‐blockers in 41% and mineralocorticoid receptor antagonists in 31% of patients. </plain></SENT>
<SENT sid="124" pm="."><plain>The frequency of use of these HF therapies appeared to be even lower among the Southeast Asian subset of patients.7 Key gaps in knowledge include reasons for under‐treatment of patients as well as the tolerability and effective HF drug doses in Southeast Asian patients, in whom smaller body sizes may impact the maximum tolerated doses or prescription habits of doctors. </plain></SENT>
</text></p></sec><sec id="ehf212036-sec-0006"><title><text><SENT sid="125" pm="."><plain>Heart failure with preserved ejection fraction in Southeast Asia </plain></SENT>
</text></title><p><text><SENT sid="126" pm="."><plain>The high prevalence of hypertension and rapidly ageing societies in Southeast Asia portend a large increase in heart failure with preserved ejection fraction (HFpEF). </plain></SENT>
<SENT sid="127" pm="."><plain>Currently, very little is known regarding the prevalence and outcome of patients with HFpEF from Southeast Asia. </plain></SENT>
<SENT sid="128" pm="."><plain>Retrospective single‐centre studies have reported prevalences of HFpEF ranging from 17–38%.4, 9, 10 Most recently, the 2‐year mortality in 751 patients with HFpEF from Singapore was found to be 26.6% (compared with 37.1% in patients with reduced ejection fraction [HR 0.618; 95% CI 0.508–0.753]), with no ethnic differences.10 </plain></SENT>
</text></p></sec><sec id="ehf212036-sec-0007"><title><text><SENT sid="129" pm="."><plain>Advanced heart failure therapies in Southeast Asia </plain></SENT>
</text></title><p><text><SENT sid="130" pm="."><plain>Data are scarce regarding the use of advanced HF therapies, such as device therapy (implantable cardiac defibrillators, cardiac resynchronization therapy and left ventricular assist devices) and cardiac transplantation, in Southeast Asia. </plain></SENT>
<SENT sid="131" pm="."><plain>Small single‐centre studies have described marked under‐usage of device therapies in guideline‐indicated cases11 and conflicting efficacy data in Asian patients.12, 13 Important gaps in knowledge include real world rates of key clinical events (such as sudden cardiac death) in Southeast Asian HF patients, cost‐effectiveness of device therapy within the varied healthcare systems of Southeast Asia and sociocultural barriers to device therapy. </plain></SENT>
<SENT sid="132" pm="."><plain>These issues are being assessed prospectively in the ongoing Asian Sudden Cardiac Death in Heart Failure (ASIAN‐HF) Registry [<ext-link ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</ext-link> Identifier: NCT01633398].14 </plain></SENT>
</text></p></sec><SecTag type="CONCL"><sec id="ehf212036-sec-0008"><title><text><SENT sid="133" pm="."><plain>Conclusions </plain></SENT>
</text></title><p><text><SENT sid="134" pm="."><plain>The facts and figures show that HF is a bourgeoning problem in Southeast Asia, fueled by a rapidly growing population with Stage A HF risk factors particularly hypertension, diabetes, in spite of relative lack of obesity, and smoking. </plain></SENT>
<SENT sid="135" pm="."><plain>Limited data in symptomatic Stage C HF patients from Southeast Asia indicate that HF hospitalizations are on the rise, and that compared with Western counterparts, HF decompensation occurs at a younger age and yet is characterized by more severe clinical features and worse outcomes in Southeast Asian patients. </plain></SENT>
<SENT sid="136" pm="."><plain>Important inter‐ethnic differences exist, wherein Malay patients appear to fare worse than Indian or Chinese patients, for reasons that are poorly understood. </plain></SENT>
<SENT sid="137" pm="."><plain>Under‐usage of disease‐modifying HF therapies has been reported among Southeast Asian patients. </plain></SENT>
<SENT sid="138" pm="."><plain>There are large gaps in knowledge pertaining to the prevalence of HFpEF, clinical outcomes, barriers to recommended therapies and their cost‐effectiveness in Southeast Asia, as well as possible ethnicity specific pathophysiologic mechanisms. </plain></SENT>
<SENT sid="139" pm="."><plain>These gaps will hopefully be addressed in ongoing studies (SHOP,8 PEOPLE,8 ASIAN‐HF14). </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="REF"><ref-list content-type="cited-references" id="ehf212036-bibl-0001"><title>References</title><ref id="ehf212036-bib-0001"><text><SENT sid="140" pm="."><plain>1  Hunt SA ,  Baker DW ,  Chin MH ,  Cinquegrani MP ,  Feldman AM ,  Francis GS ,  Ganiats TG ,  Goldstein S ,  Gregoratos G ,  Jessup ML ,  Noble RJ ,  Packer M ,  Silver MA ,  Stevenson LW ,  Gibbons RJ ,  Antman EM ,  Alpert JS ,  Faxon DP ,  Fuster V ,  Gregoratos G ,  Jacobs AK ,  Hiratzka LF ,  Russell RO ,  Smith SC Jr . American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure); International Society for Heart and Lung Transplantation; Heart Failure Society of America. </plain></SENT>
<SENT sid="141" pm="."><plain>ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 2001;104:2996–3007.11739319 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0002"><text><SENT sid="142" pm="."><plain>2  Ponikowski P ,  Anker SD ,  AlHabib KF ,  Cowie MR ,  Force TL ,  Hu SS ,  Jaarsma T ,  Krum H ,  Rastogi V ,  Rohde LE ,  Samal UC ,  Shimokawa H ,  Siswanto BB ,  Sliwa K ,  Filippatos G . Heart failure: preventing disease and death worldwide. ESC Heart Failure 2014;1:4–25.28834669 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0003"><text><SENT sid="143" pm="."><plain>3  Ng TP ,  Niti M . Trends and ethnic differences in hospital admissions and mortality for congestive heart failure in the elderly in Singapore, 1991 to 1998. Heart 2003;89:865–870.12860859 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0004"><text><SENT sid="144" pm="."><plain>4  Lee R ,  Chan SP ,  Chan YH ,  Wong J ,  Lau D ,  Ng K . Impact of race on morbidity and mortality in patients with congestive heart failure: a study of the multiracial population in Singapore. Int J Cardiol 2009;134:422–425.18372060 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0005"><text><SENT sid="145" pm="."><plain>5  Atherton JJ ,  Hayward CS ,  Wan Ahmad WA ,  Kwok B ,  Jorge J ,  Hernandez AF ,  Liang L ,  Kociol RD ,  Krum H . ADHERE International‐Asia Pacific Scientific Advisory Committee. </plain></SENT>
<SENT sid="146" pm="."><plain>Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific (ADHERE International‐Asia Pacific). J Card Fail 2012;18:82–88.22196846 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0006"><text><SENT sid="147" pm="."><plain>6  Yancy CW ,  Lopatin M ,  Stevenson LW ,  De Marco T ,  Fonarow GC . Clinical presentation, management, and in‐hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006;47:76–84.16386668 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0007"><text><SENT sid="148" pm="."><plain>7  Callender T ,  Woodward M ,  Roth G ,  Farzadfar F ,  Lemarie JC ,  Gicquel S ,  Atherton J ,  Rahimzadeh S ,  Ghaziani M ,  Shaikh M ,  Bennett D ,  Patel A ,  Lam CS ,  Sliwa K ,  Barretto A ,  Siswanto BB ,  Diaz A ,  Herpin D ,  Krum H ,  Eliasz T ,  Forbes A ,  Kiszely A ,  Khosla R ,  Petrinic T ,  Praveen D ,  Shrivastava R ,  Xin D ,  MacMahon S ,  McMurray J ,  Rahimi K . Heart failure care in low‐ and middle‐income countries: a systematic review and meta‐analysis. PLoS Med 2014;11:e1001699.25117081 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0008"><text><SENT sid="149" pm="."><plain>8  Santhanakrishnan R ,  Ng TP ,  Cameron VA ,  Gamble GD ,  Ling LH ,  Sim D ,  Leong GK ,  Yeo PS ,  Ong HY ,  Jaufeerally F ,  Wong RC ,  Chai P ,  Low AF ,  Lund M ,  Devlin G ,  Troughton R ,  Richards AM ,  Doughty RN ,  Lam CS . The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and prospective evaluation of outcome in patients with heart failure with preserved left ventricular ejection fraction (PEOPLE) study: rationale and design. J Card Fail 2013;19:156–162.23482075 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0009"><text><SENT sid="150" pm="."><plain>9  Leong KT ,  Goh PP ,  Chang BC ,  Lingamanaicker J . Heart failure cohort in Singapore with defined criteria: clinical characteristics and prognosis in a multi‐ethnic hospital‐based cohort in Singapore. Singapore Med J 2007;48:408–414.17453098 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0010"><text><SENT sid="151" pm="."><plain>10  Yap J ,  Sim D ,  Lim CP ,  Chia SY ,  Go YY ,  Jaufeerally FR ,  Sim LL ,  Liew R ,  Ching CK . Predictors of two‐year mortality in Asian patients with heart failure and preserved ejection fraction. Int J Cardiol 2015;183C:33–38. </plain></SENT>
</text></ref><ref id="ehf212036-bib-0011"><text><SENT sid="152" pm="."><plain>11  Lee E ,  Chen R ,  Aziz S ,  Tan PT ,  Seow YH ,  Toon WL ,  Chai P ,  Wong R ,  Seow SC ,  Lam C . Socio cultural barriers to device therapy among Asian patients with heart failure. Eur J Heart Fail 2012;11(suppl 1):S268. </plain></SENT>
</text></ref><ref id="ehf212036-bib-0012"><text><SENT sid="153" pm="."><plain>12  Tanno K ,  Miyoshi F ,  Watanabe N ,  Minoura Y ,  Kawamura M ,  Ryu S ,  Asano T ,  Kobayashi Y ,  Katagiri T . MADIT II. </plain></SENT>
<SENT sid="154" pm="."><plain>The Multicenter Automtic Defibrillator Implantation Trial. </plain></SENT>
<SENT sid="155" pm="."><plain>Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? Circ J 2005;69:19–22.15635196 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0013"><text><SENT sid="156" pm="."><plain>13  Siu CW ,  Pong V ,  Ho HH ,  Liu S ,  Lau CP ,  Li SW ,  Tse HF . Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients? J Cardiovasc Electrophysiol 2010;21:231–235.19804551 </plain></SENT>
</text></ref><ref id="ehf212036-bib-0014"><text><SENT sid="157" pm="."><plain>14  Lam CS ,  Anand I ,  Zhang S ,  Shimizu W ,  Narasimhan C ,  Park SW ,  Yu CM ,  Ngarmukos T ,  Omar R ,  Reyes EB ,  Siswanto B ,  Ling LH ,  Richards AM . Asian Sudden Cardiac Death in Heart Failure (ASIAN‐HF) registry. Eur J Heart Fail 2013;15:928–936.23568645 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
